Skip to main content

Table 2 Clinical factor screening information sheet

From: A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma

Clinical characteristics TCGA (N = 181) Uni-variables cox Multi-variables cox
HR 95%CI P HR 95%CI P
Age (years, mean ± sd) 47.06 ± 13.83 1.005 0.981–1.029 6.93E−01
Neoplasm histologic grade (G1/G2/G3/–) 11/77/77/16 1.219 0.655–2.269 5.30E−01
Pathologic M (M0/M1/–) 79/3/99 11.060 1.130- 108.2 9.48E−03 5.960 0.598–59.39 1.28E−01
Pathologic N (N0/N1/–) 97/30/54 3.410 1.541–7.547 1.33E−03 3.238 1.468–7.142 3.61E−03
Pathologic T (T1/T2/–) 99/50/32 1.263 0.584–2.729 5.52E−01
Pathologic stage (I/II) 123/58 0.820 0.396–1.696 5.87E−01
Number of pregnancies (0/1/2/3/over 3/–) 10/18/30/28/75/20 1.028 0.794–1.333 8.31E−01
Radio-therapy (yes/no/–) 105/53/23 1.190 0.571–2.479 6.42E−01
RS model status (high/low) 90/91 3.485 1.717–7.076 2.35E−04 2.518 1.122–5.651 2.51E−02
Vital status (dead/alive) 38/143
Overall survival time (months, mean ± sd) 37.83 ± 40.02
  1. HR, hazard ratio; CI, confidence interval; N, number